Mirati Therapeutics, Inc.·4

Jan 22, 6:00 PM ET

Donadio Jamie A 4

4 · Mirati Therapeutics, Inc. · Filed Jan 22, 2018

Insider Transaction Report

Form 4
Period: 2018-01-18
Donadio Jamie A
VP of Finance
Transactions
  • Award

    Option Grant (Right to Buy)

    2018-01-18+50,00050,000 total
    Exercise: $27.00Exp: 2028-01-17Common Stock (50,000 underlying)
Footnotes (1)
  • [F1]1/4th of the shares subject to the Option shall vest and become exercisable on the first anniversary of the date of grant, and 1/48th of the shares subject to the Option shall vest each month thereafter until fully vested.

Documents

2 files
  • 4
    marketforms-40832.xmlPrimary

    PRIMARY DOCUMENT

  • EX-24

    POA DOCUMENT